Company Analysis
Sign in

ProMIS Neurosciences Inc. (PMN)

Nasdaq: PMN · Pharmaceutical Preparations · Toronto, ON · filing with the SEC since 2006
Full chart Alerts Compare
Grade4.4
◀ Past 3.7● Present 3.1▶ Future 5.9
6 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021
Report filedMar 25, 2026Mar 31, 2025Apr 1, 2024Mar 8, 2023·
Research and development33,379,32110,637,9767,883,16516,087,1684,627,386
General and administrative6,787,9876,189,5026,379,5687,292,7443,663,707
Total operating expenses40,167,30816,827,47814,262,73323,379,9128,291,093
Operating income-40,167,308-16,827,478-14,262,733-23,379,912-8,291,093
Interest expense···282,064416,286
Other income (expense), net442,569626,184384,903115,52512,909
Total non-operating income (expense)448,16119,606,3511,050,2515,317,649-1,499,013
Income tax expense·000·
Net income including non-controlling interests-39,719,1472,778,873-13,212,482-18,062,263-9,790,106
Net income-39,719,1472,778,873-13,212,482-18,062,263-9,790,106
Net income to common shareholders-39,719,1472,778,873-13,212,482r18,062,2639,790,106
Earnings per share, basic-22.612.68r-26.75b-60.25b-42.25b
Earnings per share, diluted-22.612.63r-26.75b-60.25b-42.25b
Weighted average shares, basic1,756,8441,036,799r491,708b300,104b231,425b
Weighted average shares, diluted1,756,8441,058,469r491,708b300,104b231,425b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-25 reverse split of Nov 2025.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseDebt
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton PMN · research, not advice